Brockelmann PJ, Buhnen I, Meissner J, Trautmann-Grill K, et al. Nivolumab and Doxorubicin, Vinblastine, and Dacarbazine in Early-Stage Unfavorable Hodgkin Lymphoma: Final Analysis of the Randomized German Hodgkin Study Group Phase II NIVAHL Trial. J Clin Oncol 2022 Dec 12:JCO2202355. doi: 10.1200/JCO.22.02355.
PMID: 36508302